AI Buyer Insights:

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

List of NovoPath LIS Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
APDerm Healthcare 350 $35M United States NovoPath NovoPath LIS Laboratory Management 2024 n/a
In 2024 APDerm implemented NovoPath LIS for its dermatopathology and anatomic pathology lab workflows in the United States. The deployment established NovoPath LIS as the central Laboratory Management application across APDerm's pathology operations, consolidating case intake, diagnostic sign-out, and final reporting into a single system of record. Configuration emphasized laboratory case tracking and specimen accessioning, structured and templated report generation to automate reporting, and workflow orchestration for dermatopathology and anatomic pathology case types. The NovoPath LIS implementation included barcode-enabled specimen tracking, digital slide and image referencing for pathologist review, and role-based sign-out workflows to support diagnostic throughput and auditability. Operational coverage focused on the dermatopathology lab, spanning specimen reception through final report distribution and archival within NovoPath LIS. The solution aligned clinical reporting pipelines and internal distribution channels to streamline pathologist sign-out and reduce handoffs between lab functions. Governance changes accompanied the rollout, with standardized diagnostic templates, formalized sign-out procedures, and role-based access controls to support compliance and traceability. Phased user onboarding and configuration of automated report assembly reduced manual report preparation and centralized reporting authority in the LIS. Per the NovoPath case study the deployment delivered measurable operational gains for APDerm, including reduced turnaround times, automated reporting, and recovered pathology revenue. NovoPath LIS in the Laboratory Management category became the primary platform supporting dermatopathology and anatomic pathology business functions at APDerm.
Clinpath Laboratories Australia Healthcare 200 $25M Australia NovoPath NovoPath LIS Laboratory Management 2024 n/a
In 2024, Clinpath Laboratories Australia implemented NovoPath LIS across its Australian pathology operations. The deployment leveraged NovoPath 360 capabilities to streamline pathologist workflows and reporting, concentrating on anatomic pathology efficiencies and faster sign-out. The solution was delivered as a scalable SaaS deployment, enabling centralized configuration of case routing and sign-out queues for pathologists. Clinpath applied the NovoPath LIS implementation across its anatomic pathology service lines and reporting teams. Core functional usage emphasized anatomic pathology and reporting modules, including structured case creation, digital report authoring, and sign-out workflow automation aligned with Laboratory Management functions. Operational coverage focused on pathologist workstation workflows, reporting pipelines, and laboratory operations coordination within Australian sites. Governance changes included standardizing reporting templates and role based sign-off workflows to align pathologist triage and QA processes. The case study documents improved turnaround times and faster sign-out as outcomes of the NovoPath LIS deployment.
Showing 1 to 2 of 2 entries

Buyer Intent: Companies Evaluating NovoPath LIS

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating NovoPath LIS. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD NovoPath LIS Coverage

NovoPath LIS is a Laboratory Management solution from NovoPath.

Companies worldwide use NovoPath LIS, from small firms to large enterprises across 21+ industries.

Organizations such as APDerm and Clinpath Laboratories Australia are recorded users of NovoPath LIS for Laboratory Management.

Companies using NovoPath LIS are most concentrated in Healthcare, with adoption spanning over 21 industries.

Companies using NovoPath LIS are most concentrated in United States and Australia, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of NovoPath LIS across Americas, EMEA, and APAC.

Companies using NovoPath LIS range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 100%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 0%.

Customers of NovoPath LIS include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified NovoPath LIS customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Laboratory Management.